Introduction
The clinical management of geriatric patients represents a mounting challenge due to "homeostenosis"—a progressive decline in functional organ reserve that narrows the margin of safety during surgical stress [1]. With the elderly population in Odisha projected to reach 80 lakh by 2036 and a 91.7% prevalence of chronic morbidities, the magnitude of perioperative risk is substantial [2,3]. Anesthesia-related complications, ranging from cardiovascular events (10–35%) to postoperative delirium (up to 50% in hip fractures), significantly threaten functional independence and strain socio-economic resources, especially in a region where 40% of seniors have no personal income [4,5].
Current literature establishes that aging fundamentally alters drug pharmacokinetics, requiring lower induction doses for agents like propofol (1.7 mg/kg vs. 2.2 mg/kg in younger adults) [6,7]. Most data originates from high-income Western countries, despite the validation of tools like the ASA classification and Lee Cardiac Risk Index for predicting morbidity. Locally, there is a distinct lack of data regarding the "patient experience" concerning minor complications (dry mouth, somnolence) and the long-term impact of anesthetic depth on the unique nutritional and comorbidity profiles of Indian geriatric patients [9,10].
This study is founded on the framework that evidence-based, localized audits are required to bridge the gap between "expert opinion" and the specific resource constraints of Indian government medical colleges. By utilizing a multivariable logistic regression model, the research aims to identify independent risk factors, such as the correlation between specific drug dosages and hemodynamic instability [11]. The project’s specific purpose is to document real-world anesthetic management, compare outcomes between regional and general anesthesia, and validate risk-stratification tools to develop localized clinical protocols, such as "geriatric-dose" induction cards, to improve perioperative safety [6,12].
Materials and Methods
We conducted a quantitative, observational, and retrospective descriptive-analytical study at a tertiary care government medical college in Odisha. Researchers utilized hospital records from the inpatient department and operation theater databases covering a two-year period from January 2022 to December 2023. We identified a study population consisting of all patients aged 65 years and older who underwent elective or emergency surgical procedures requiring anesthesia.
We employed a consecutive purposive sampling method, sequentially analyzing every eligible record that met our inclusion criteria.
The inclusion criteria targeted patients aged 65 or older who received general anesthesia, regional anesthesia, or monitored anesthesia care and possessed complete medical records. We excluded patients under 65, those with missing or illegible charts, and those undergoing surgery under local anesthesia without the anesthesiology team.
For the analytical phase, patients who met the age criteria but remained free of complications served as an internal comparator to identify independent risk factors. We extracted data for several independent variables, including demographic data, preoperative ASA status, comorbidities, surgical factors (type and duration), and anesthetic management details such as specific drug dosages. We monitored several dependent variables to assess clinical outcomes. These included hemodynamic complications like hypotension and bradycardia, respiratory issues such as desaturation or re-intubation, and neurocognitive markers like postoperative delirium. We also recorded minor complications, including nausea, sore throat, and somnolence, alongside broader outcomes like length of hospital stay and 30-day mortality. Finally, we retrieved and reviewed laboratory investigation parameters from the records, including hematology, biochemistry, ECG findings, and preoperative chest X-rays, to correlate clinical status with anesthetic outcomes.
Results
The study population consisted of 300 elderly patients, with a slight female majority (53%) and a primary age concentration in the 65–74 year bracket (55%). A high clinical risk profile was observed, as 58% of the cohort was classified as ASA physical status III or IV, indicating severe systemic disease. Furthermore, hypertension was the most prevalent comorbidity, affecting 72% of patients, followed by diabetes mellitus at 43%, highlighting a significant burden of cardiovascular and metabolic disease within the group (Table 1).
| Variable | Category | Total (n=300) | Percentage (%) |
| Age Group | 65–74 years | 165 | 55% |
| 75–84 years | 102 | 34% | |
| ≥ 85 years | 33 | 11% | |
| Gender | Male | 142 | 47% |
| Female | 158 | 53% | |
| BMI (kg/m²) | Underweight (<18.5) | 42 | 14% |
| Normal (18.5–24.9) | 186 | 62% | |
| Overweight/Obese (≥25) | 72 | 24% | |
| ASA Physical Status | ASA I | 12 | 4% |
| ASA II | 114 | 38% | |
| ASA III | 148 | 49% | |
| ASA IV | 26 | 9% | |
| Comorbidities | Hypertension | 215 | 72% |
| Diabetes Mellitus | 128 | 43% | |
| Coronary Artery Disease | 84 | 28% | |
| Chronic Obstructive Pulmonary Disease | 46 | 15% | |
| Renal Dysfunction | 32 | 11% |
Statistically significant differences were observed between general anesthesia (GA) and regional anesthesia (RA) across all management factors. Patients receiving RA underwent significantly shorter procedures (84.6 ± 28.5 mins) compared to those under GA (112.4 ± 34.2 mins; p < 0.001). Additionally, GA was more frequently utilized for emergency surgeries (p = 0.042) and required a higher rate of invasive monitoring (22.3% vs. 10.7%; p = 0.012), suggesting a higher level of complexity or acuity in the general anesthesia group (Table 2).
| Management Factor | General Anesthesia (n=188) | Regional Anesthesia (n=112) | p-value |
| Surgical Priority | Elective: 120 / Emer: 68 | Elective: 88 / Emer: 24 | 0.042 |
| Induction Agent | Propofol: 1.8 ± 0.4 mg/kg | N/A | -- |
| Adjuvant Opioid | Fentanyl: 1.2 ± 0.3 µg/kg | N/A | -- |
| Duration of Surgery | 112.4 ± 34.2 mins | 84.6 ± 28.5 mins | <0.001 |
| Invasive Monitoring | IBP/CVP: 42 (22.3%) | IBP/CVP: 12 (10.7%) | 0.012 |
Hemodynamic instability was the most frequent complication, with hypotension occurring in 23% of cases. Neurocognitive issues were also notable, specifically postoperative delirium (14%) and excessive somnolence (21%). Minor complications were relatively common, as evidenced by an 18% incidence of postoperative nausea and vomiting and a 16% incidence of sore throat, indicating that while major respiratory events remained below 10%, subjective and hemodynamic disturbances were prevalent in the postoperative period (Table 3).
| Category | Specific Complication | Frequency (n) | Incidence (%) |
| Hemodynamic | Hypotension (SBP <90 mmHg) | 68 | 23% |
| Bradycardia (HR <50 bpm) | 34 | 11% | |
| Arrhythmias | 18 | 6% | |
| Respiratory | Desaturation (SpO2 <90%) | 28 | 9% |
| Postoperative Pneumonia | 12 | 4% | |
| Neurocognitive | Postoperative Delirium (POD) | 42 | 14% |
| Delayed Emergence | 16 | 5% | |
| Minor/Subjective | Postoperative Nausea/Vomiting | 54 | 18% |
| Sore Throat | 48 | 16% | |
| Excessive Somnolence | 62 | 21% |
The multivariable analysis identified ASA status (III/IV) as the strongest independent predictor of adverse outcomes, with patients having more than triple the risk of complications (aOR 3.42; p < 0.001). Other significant risk factors included a propofol dose exceeding 1.5 mg/kg (aOR 2.56; p = 0.001), age ≥ 75 years (aOR 2.14; p = 0.008), and surgery duration longer than 120 minutes (aOR 1.95; p = 0.018). Notably, general anesthesia itself did not reach statistical significance as an independent risk factor when adjusted for other variables (p = 0.092) (Table 4).
| Risk Factor | Adjusted Odds Ratio (aOR) | 95% Confidence Interval (CI) | p-value |
| Age ≥ 75 years | 2.14 | 1.22–3.76 | 0.008 |
| ASA Status (III/IV) | 3.42 | 1.84–6.35 | <0.001 |
| Emergency Surgery | 1.88 | 1.04–3.38 | 0.036 |
| Propofol Dose > 1.5mg/kg | 2.56 | 1.45–4.52 | 0.001 |
| General Anesthesia | 1.64 | 0.92–2.94 | 0.092 |
| Surgery Duration > 120m | 1.95 | 1.12–3.40 | 0.018 |
Patients who experienced complications exhibited significantly different baseline laboratory profiles compared to the non-complication group. Most notably, the complication group had significantly lower hemoglobin levels (10.2 vs. 11.8 g/dL; p < 0.001) and higher blood glucose levels (154 vs. 128 mg/dL; p < 0.001). Furthermore, the presence of abnormal preoperative ECG or CXR findings was nearly twice as common in the complication group (67.8% vs. 34.4%; p < 0.001), suggesting that preoperative physiological optimization and screening are strongly linked to clinical outcomes (Table 5).
| Lab Parameter | Complication Group (n=56) | Non-Complication Group (n=244) | p-value |
| Hemoglobin (g/dL) | 10.2 ± 1.4 | 11.8 ± 1.2 | <0.001 |
| Serum Creatinine (mg/dL) | 1.4 ± 0.5 | 1.1 ± 0.3 | 0.002 |
| Blood Glucose (mg/dL) | 154 ± 38 | 128 ± 26 | <0.001 |
| Serum Potassium (mEq/L) | 3.8 ± 0.6 | 4.1 ± 0.4 | 0.045 |
| Abnormal ECG/CXR | 38 (67.8%) | 84 (34.4%) | <0.001 |
Discussion
The current study in Odisha confirms that geriatric patients exhibit significant systemic vulnerability, with 58% classified as ASA III/IV, validating the rationale of homeostenosis—a narrowed functional reserve against surgical stress [13]. Multivariable regression successfully addressed the primary aim by identifying ASA status (aOR 3.42) and excessive propofol dosing (>1 mg/kg; aOR 2.56) as potent independent risk factors for complications, such as the 23% incidence of hypotension observed [14,15]. A primary strength of this project lies in its "real-world" regional specificity within a resource-constrained government medical college, capturing the critical interplay between biological aging, anemia, and socio-economic constraints that Western data often overlooks [5,16]. By disentangling complex variables through regression, the study pinpointed that physiological substrate and pharmacological precision—specifically avoiding induction "overdoses"—are more critical to outcomes than the choice of general versus regional anesthesia (GA vs. RA) [14,17].
The association between anesthetic interventions and outcomes is mediated by blunted baroreceptor reflexes and reduced "cognitive reserve," where high-dose propofol precipitates hemodynamic collapse and prolonged surgery increases neuroinflammatory stress, leading to a 14% delirium rate [18]. While these findings align with international concerns regarding propofol sensitivity, the 14% delirium incidence is lower than some regional reports, likely due to the inclusion of elective cases [19]. Strategically, the project impacts the healthcare system by advocating for "geriatric-dose" induction cards and preoperative anemia optimization, shifting the focus from high-volume throughput to patient-centered "brain health" initiatives [20]. This approach addresses the economic burden on a population where 40% are financially dependent, ensuring that safer perioperative care prevents catastrophic health expenditures [5,21].
Discrepancies between anticipated and observed outcomes revealed that GA was not an independent risk factor for complications (p > 0.05), as its perceived risk was confounded by its use in more complex, urgent surgeries [22]. Furthermore, the unexpectedly high rate of somnolence (21%) likely reflects the regional nutritional context; low albumin levels in underweight patients (14%) increase the "free fraction" of drugs, turning standard doses into relative overdoses [23]. This necessitates a strategic trade-off where the time invested in "geriatric-specific" regional techniques or invasive monitoring is balanced against theater throughput [24,25]. Ultimately, the higher cost of managing a single complication like AKI or delirium justifies the opportunity cost of slower, more meticulous anesthetic induction and preoperative optimization in high-risk (ASA III/IV) seniors [18,26].
Despite its strengths, the study’s generalizability is limited by its single-center design and a small "oldest-old" (>85 years) subgroup (11%), which may require even more aggressive dose titration [5]. Internal validity was challenged by the retrospective nature of chart reviews and potential selection bias in anesthetic choice; the 14% delirium rate may also under represent hypoactive cases due to the lack of structured CAM assessments [27,28]. To mitigate these limits, multivariable regression was employed to adjust for confounders, and the use of consecutive, purposive sampling (n=300) over two years provided high statistical power [27]. Correlating clinical complications with objective laboratory data (e.g., hemoglobin and glucose) further strengthened the study’s conclusions, providing actionable evidence for localized, risk-stratified perioperative protocols in Odisha [16].
Conclusion
Geriatric perioperative care in Odisha is challenged by "homeostenosis" and a high prevalence of ASA III/IV status (58%), with adverse outcomes primarily driven by physiological vulnerability—age ≥75 years (aOR 2.14) and ASA III/IV (aOR 3.42)—rather than the choice of anesthesia. Pharmacological precision is critical, as propofol doses >1.5 mg/kg significantly increase complication risks (aOR 2.56), while high rates of hemodynamic instability (23%) and neurocognitive issues (21% somnolence, 14% delirium) highlight the need for geriatric-specific dosing over standard protocols. Furthermore, the strong correlation between complications and preoperative anemia or abnormal ECGs (p < 0.001) confirms that physiological optimization is as vital as intraoperative management. To improve safety, we recommend implementing localized "geriatric-dose" induction cards and mandatory anemia correction, shifting from high-volume throughput to risk-stratified, patient-centered care to preserve functional independence and reduce socio-economic burdens in resource-constrained settings.
Declarations
Ethics approval and consent to participate
Not required as it is a retrospective study.
Data Availability
The datasets generated and analyzed during the current study are available from the corresponding author upon reasonable request.
Conflicts of Interest
The authors declare that they have no competing interests.
Funding
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Acknowledgments
None
Author Contributions
All authors contributed equally to the conceptualization, data collection, drafting of the manuscript, critical revision, and final approval of the version to be published.